The EPS projection of Thermo Fisher Scientific Inc (NYSE:TMO) for quarter ended 2016-09-30 is $2.02. A week before, the EPS forecast was $2.02 against target of $2.02, a month earlier. This estimate stood at $2.02 60 days earlier versus forecast of $2.02 90 days earlier, confirming a deviation of 0%.
Thermo Fisher Scientific Inc (NYSE:TMO) reported that 18 days ago, the positive EPS revisions were 2 and negative revisions at 1.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 9, 9, 0 and 9, respectively.
The downgrade of EPS estimates for Thermo Fisher Scientific Inc (NYSE:TMO) in the preceding 120, 60, 30 and 90 days were 0, 0, 0 and 0, in that order.
As per the latest update, for the quarter closed 1, the EPS estimate of Thermo Fisher Scientific Inc (NYSE:TMO) was $2.02. This projection was computed after accounting 11 calls. As reported on 2016-04-28 the EPS was $1.8. The change was $0.06, demonstrating a percentage deviation of 3.45%. The projections confirmed a standard deviation of 0.02.
Quarterly Sales Estimates
For the fiscal 2017, the yearly sales target for Thermo Fisher Scientific Inc (NYSE:TMO) stands at $4984.35 and the median estimate at $4984.35. Almost 2 analysts announced their estimates.
The highest estimate is $5030 while the lowest target is $4938.7 showing standard deviation of 64.558%.
As many as 2 analysts released sales estimates reised in upside while 2 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 2 revised sales number projection on upside while 2 lowered the sales target, demonstrating a deviation of 0%.
A quarter ago, 2 hiked sales estimations and 2 reduced sales forecast. Thermo Fisher Scientific Inc (NYSE:TMO) stated that the change in forecast was -0.218%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...